MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ATRA has $30,167K in assets. $66,801K in debts. $5,742K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
102.08%
Quick Ratio
102.08%
Cash Ratio
31.80%
Debt to Asset Ratio
221.44%
Assets Breakdown
    • Operating lease assets
    • Short-term investments
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Liability related to the sale of...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
5,742 16,903
Short-term investments
7,970 5,420
Restricted cash
0 0
Accounts receivable
1,913 0
Inventories
0 0
Other current assets
2,807 2,449
Total current assets
18,432 24,772
Property and equipment, gross
551 -
Less accumulated depreciation
404 -
Property and equipment, net
147 176
Operating lease assets
10,707 11,027
Other assets
881 927
Total assets
30,167 36,902
Accounts payable
318 1,762
Accrued compensation
2,067 2,552
Accrued research and development expenses
342 971
Deferred revenue
1,011 1,607
Liability related to the sale of future revenues - current portion
9,670 -
Other current liabilities
4,649 7,671
Total current liabilities
18,057 14,563
Operating lease liabilities - long-term
15,005 15,426
Deferred revenue - long-term
-0
Liability related to the sale of future revenues - long-term
31,976 40,222
Other long-term liabilities
1,763 1,732
Total liabilities
66,801 71,943
Common stock - 0.0001 par value, 500,000 shares authorized as of september 30, 2025 and december 31, 2024 7,210 and 5,859 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
1 1
Additional paid-in capital
1,981,822 1,979,114
Accumulated other comprehensive income (loss)
2 0
Accumulated deficit
-2,018,459 -2,014,156
Total stockholders' equity (deficit)
-36,634 -35,041
Total liabilities and stockholders' equity (deficit)
30,167 36,902
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Property and equipment,gross$551K Other current assets$2,807K Accounts receivable$1,913K Short-term investments$7,970K Cash and cashequivalents$5,742K Other assets$881K Operating lease assets$10,707K Property and equipment,net$147K Total current assets$18,432K Less accumulateddepreciation$404K Total assets$30,167K Accumulated deficit-$2,018,459K Total liabilities andstockholders' equity...$30,167K Total stockholders'equity (deficit)-$36,634K Accumulated othercomprehensive income (loss)$2K Additional paid-in capital$1,981,822K Common stock - 0.0001par value, 500,000...$1K Total liabilities$66,801K Other long-termliabilities$1,763K Liability related to thesale of future...$31,976K Operating leaseliabilities - long-term$15,005K Total currentliabilities$18,057K Other currentliabilities$4,649K Liability related to thesale of future...$9,670K Deferred revenue$1,011K Accrued research anddevelopment expenses$342K Accrued compensation$2,067K Accounts payable$318K

Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics, Inc. (ATRA)